(Q45885454)

17 December 2017

title

Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100. (English)

1 reference

17 December 2017

1 reference

Xia DJ

1

1 reference

17 December 2017

Zhang WP

2

1 reference

17 December 2017

Zheng S

3

1 reference

17 December 2017

Wang J

4

1 reference

17 December 2017

Pan JP

5

1 reference

17 December 2017

Wang Q

6

1 reference

17 December 2017

Zhang LH

7

1 reference

17 December 2017

Hamada H

8

1 reference

17 December 2017

Cao X

9

1 reference

17 December 2017

publication date

1 May 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

9

1 reference

17 December 2017

page(s)

592-601

1 reference

17 December 2017

Dendritic cells in cancer immunotherapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Gene-modified dendritic cells for use in tumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Human chemokines: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

The makings of a tumor rejection antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

The expanding universe of T-cell subsets: Th1, Th2 and more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Migratory response of human natural killer cells to lymphotactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Combined chemokine and cytokine gene transfer enhances antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301694

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301694

1 reference

17 December 2017

Dimensions Publication ID

1029250173

0 references

1 reference

17 December 2017